Suchergebnisse - "Mah, Jean K"

PubPharm (6)

1

Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy : A 30-Month Nonrandomized Controlled Open-Label Extension Trial

enthalten in: JAMA network open | 2022

von Mah, J. | Clemens, P. | Guglieri, M. | +125

2

Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy

enthalten in: Journal of neuromuscular diseases | 2022

von Clemens, P. | Rao, V. | Connolly, A. | +8

3

Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

enthalten in: Neurology | 2019

von Hoffman, E. | Schwartz, B. | Mengle-Gaw, L. | +28

4

Early corneal nerve fibre damage and increased Langerhans cell density in children with type 1 diabetes mellitus

enthalten in: Scientific reports | 2019

von Ferdousi, M. | Romanchuk, K. | Mah, J. | +4

5

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy : a prospective cohort study

enthalten in: Lancet (London, England) | 2018

von McDonald, C. | Henricson, E. | Abresch, R. | +44

CommentIn: Lancet. 2018 Feb 3;391(10119):406-407. - PMID 29174483

6

Facioscapulohumeral dystrophy in children : design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD)

enthalten in: BMC neurology | 2016

von Goselink, R. | Schreuder, T. | Mul, K. | +11

1
[1]